Breaking News Instant updates and real-time market news.

GTXI

GTx

$16.43

-0.93 (-5.36%)

13:44
05/15/18
05/15
13:44
05/15/18
13:44

Stifel bullish on GTx ahead of SUI trial data readout

Stifel analyst Adam Walsh suspects GTx shares are down today on balance sheet concerns following the company's earnings report. However, he does not share those worries and remains bullish on the stock ahead of the expected readout of the company's Phase 2 ASTRID trial, which may come as early as October of this year. Additionally, GTx may present further durability data on the trial of enobosarm in postmenopausal women with stress urinary incontinence at the AUA meeting on May 18, which could also move shares higher, said Walsh. He maintains a Buy rating and $45 price target on GTx.

GTXI GTx
$16.43

-0.93 (-5.36%)

11/09/17
STFL
11/09/17
INITIATION
Target $16
STFL
Buy
GTx initiated with a Buy at Stifel
Stifel analyst Adam Walsh started GTx with a Buy rating and a $16 price target, saying he believes its lead pipeline asset enobosarm in treating postmenopausal women with stress urinary incontinence has blockbuster potential. SUI is "an enormous indication with no FDA approved drugs," Walsh added.
11/09/17
11/09/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. AnaptysBio (ANAB) initiated with a Buy at Jefferies. 2. Regenxbio (RGNX) resumed with an Overweight at Morgan Stanley. 3. GTx (GTXI) initiated with a Buy at Stifel. 4. Idera Pharmaceuticals (IDRA) initiated with a Buy at H.C. Wainwright. 5. Nektar (NKTR) initiated with a Buy at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/21/17
BARD
11/21/17
INITIATION
Target $17
BARD
Outperform
GTx initiated with an Outperform at Baird
Baird analyst Michael Ulz initiated GTx with an Outperform rating. Based on promising activity and a well designed study, he expects positive data from the ongoing Phase 2 ASTRID study by year-end 2018 to drive meaningful upside, saying enobosarm represents a blockbuster market opportunity. Ulz has a $17 price target on GTx shares.
03/05/18
STFL
03/05/18
NO CHANGE
Target $45
STFL
Buy
GTx price target nearly tripled to $45 at Stifel after data 'steal' SUFU meeting
Stifel analyst Adam Walsh said new data presented on GTX Inc.'s phase 2 proof-of-concept study testing enobosarm in female patients stress urinary incontinence "stole the show" at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, or SUFU, Winter Meeting this weekend. Key Opinion Leaders, or KOLs, view the off-drug durability of effect data as "highly impressive" and new MRI data "strongly supports" mechanism of action, Walsh told investors. His "informal polling" of KOLs came up with predictions on probability of ultimate enobosarm approval in SUI ranging from a low of over 50% to a high of 80%, added Walsh, who raised his price target on GTX shares to $45 from $16 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

COST

Costco

$227.35

1.68 (0.74%)

07:26
08/21/18
08/21
07:26
08/21/18
07:26
Recommendations
Costco analyst commentary  »

Costco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

LB

L Brands

$33.07

0.53 (1.63%)

07:26
08/21/18
08/21
07:26
08/21/18
07:26
Recommendations
L Brands analyst commentary  »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

MGM

MGM Resorts

$28.59

0.035 (0.12%)

, CZR

Caesars

$10.05

0.05 (0.50%)

07:25
08/21/18
08/21
07:25
08/21/18
07:25
Recommendations
MGM Resorts, Caesars analyst commentary  »

Room survey suggests…

MGM

MGM Resorts

$28.59

0.035 (0.12%)

CZR

Caesars

$10.05

0.05 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$225.37

2.76 (1.24%)

07:24
08/21/18
08/21
07:24
08/21/18
07:24
Initiation
Lennox initiated  »

Lennox initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

HCSG

Healthcare Services

$41.33

0.11 (0.27%)

07:23
08/21/18
08/21
07:23
08/21/18
07:23
Conference/Events
Healthcare Services management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 29

    Aug

GTT

GTT Communications

$38.30

-0.7 (-1.79%)

07:23
08/21/18
08/21
07:23
08/21/18
07:23
Recommendations
GTT Communications analyst commentary  »

GTT Communications should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOE

Ferro

$21.23

-0.06 (-0.28%)

07:22
08/21/18
08/21
07:22
08/21/18
07:22
Conference/Events
Ferro management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 11

    Sep

TSS

TSYS

$94.88

-0.01 (-0.01%)

07:21
08/21/18
08/21
07:21
08/21/18
07:21
Recommendations
TSYS analyst commentary  »

TSYS price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 17

    Sep

  • 06

    Nov

FITB

Fifth Third

$29.83

0.145 (0.49%)

07:21
08/21/18
08/21
07:21
08/21/18
07:21
Conference/Events
Fifth Third management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 23

    Oct

YRCW

YRC Worldwide

$9.11

0.11 (1.22%)

07:21
08/21/18
08/21
07:21
08/21/18
07:21
Conference/Events
YRC Worldwide management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 06

    Nov

MDT

Medtronic

$90.06

-0.54 (-0.60%)

07:20
08/21/18
08/21
07:20
08/21/18
07:20
Hot Stocks
Breaking Hot Stocks news story on Medtronic »

Medtronic up 4.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 23

    Aug

  • 05

    Sep

  • 12

    Sep

ECOM

ChannelAdvisor

$12.95

-0.15 (-1.15%)

07:20
08/21/18
08/21
07:20
08/21/18
07:20
Conference/Events
ChannelAdvisor management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 23

    Aug

  • 28

    Aug

  • 06

    Sep

  • 07

    Sep

JCI

Johnson Controls

$38.73

0.48 (1.25%)

07:20
08/21/18
08/21
07:20
08/21/18
07:20
Upgrade
Johnson Controls rating change  »

Johnson Controls upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$114.62

-0.13 (-0.11%)

07:19
08/21/18
08/21
07:19
08/21/18
07:19
Periodicals
JPMorgan to launch new investing app for free, CNBC reports »

JPMorgan has plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 26

    Feb

DLB

Dolby

$68.32

-0.75 (-1.09%)

07:19
08/21/18
08/21
07:19
08/21/18
07:19
Conference/Events
Dolby management to meet with William Blair »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 28

    Aug

  • 06

    Sep

EPAM

Epam Systems

$136.36

1.355 (1.00%)

07:18
08/21/18
08/21
07:18
08/21/18
07:18
Recommendations
Epam Systems analyst commentary  »

Epam Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZO

Carrizo Oil & Gas

$22.79

0.05 (0.22%)

07:17
08/21/18
08/21
07:17
08/21/18
07:17
Conference/Events
Carrizo Oil & Gas management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

BBY

Best Buy

$79.39

0.91 (1.16%)

, AMZN

Amazon.com

$1,875.45

-6.49 (-0.34%)

07:17
08/21/18
08/21
07:17
08/21/18
07:17
Recommendations
Best Buy, Amazon.com analyst commentary  »

Best Buy valuation…

BBY

Best Buy

$79.39

0.91 (1.16%)

AMZN

Amazon.com

$1,875.45

-6.49 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 13

    Sep

ACRS

Aclaris Therapeutics

$16.01

0.34 (2.17%)

07:17
08/21/18
08/21
07:17
08/21/18
07:17
Hot Stocks
Aclaris Therapeutics announces ATI-450 findings in publication »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$53.81

0.51 (0.96%)

07:17
08/21/18
08/21
07:17
08/21/18
07:17
Recommendations
U.S. Bancorp analyst commentary  »

U.S. Bancorp capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRON

Cronos Group

$7.33

0.78 (11.91%)

07:16
08/21/18
08/21
07:16
08/21/18
07:16
Hot Stocks
Cronos Group announces initial supply agreement for retail distribution »

Cronos Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOME

At Home Group

$34.01

0.06 (0.18%)

07:15
08/21/18
08/21
07:15
08/21/18
07:15
Recommendations
At Home Group analyst commentary  »

At Home Group's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

AZPN

Aspen Technology

$107.56

-0.21 (-0.19%)

07:15
08/21/18
08/21
07:15
08/21/18
07:15
Recommendations
Aspen Technology analyst commentary  »

Aspen Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:15
08/21/18
08/21
07:15
08/21/18
07:15
General news
Treasury Market Outlook: Treasury yields are higher »

Treasury Market Outlook:…

NEO

NeoGenomics

$12.85

0.165 (1.30%)

07:15
08/21/18
08/21
07:15
08/21/18
07:15
Initiation
NeoGenomics initiated  »

NeoGenomics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.